News | July 14, 2024
Veerhealth Care secures export order from US Institutional Supplier
The company is planning to expand its plant capacity in in Vapi
The company is planning to expand its plant capacity in in Vapi
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Laurus Labs receives EIR from USFDA for API facilities
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
There was no observation related to data integrity reported
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Subscribe To Our Newsletter & Stay Updated
